Rosa M. Álvarez
Hospital General Universitario Gregorio Marañón(ES)
Publications by Year
Research Areas
Synthesis and biological activity, PI3K/AKT/mTOR signaling in cancer, Cancer Mechanisms and Therapy, Quinazolinone synthesis and applications, Receptor Mechanisms and Signaling
Most-Cited Works
- → Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies(2017)166 cited
- → Discovery of a New Series of Centrally Active Tricyclic Isoxazoles Combining Serotonin (5-HT) Reuptake Inhibition with α2-Adrenoceptor Blocking Activity(2004)49 cited
- → Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors(2012)44 cited
- → Novel Approach for Chemotype Hopping Based on Annotated Databases of Chemically Feasible Fragments and a Prospective Case Study: New Melanin Concentrating Hormone Antagonists(2009)32 cited
- → Imidazo[1,2-a]pyrazines as novel PI3K inhibitors(2012)32 cited
- → Tricyclic isoxazolines: Identification of R226161 as a potential new antidepressant that combines potent serotonin reuptake inhibition and α2-adrenoceptor antagonism(2007)31 cited
- → Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and α2-adrenoceptor antagonistic activities: a novel series of potential antidepressants(2003)26 cited
- → Fragment-Hopping-Based Discovery of a Novel Chemical Series of Proto-Oncogene PIM-1 Kinase Inhibitors(2012)25 cited
- → 4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives as non-peptidic selective δ-opioid agonists with potential anxiolytic/antidepressant properties. Part 2(2007)22 cited
- → Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors(2020)21 cited